Application 206099

Type: NDA
Sponsor: CURRAX

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ONZETRA XSAIL	SUMATRIPTAN SUCCINATE	POWDER;NASAL	EQ 11MG BASE	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N206099-001	ONZETRA XSAIL	SUMATRIPTAN SUCCINATE	EQ 11MG BASE	POWDER / NASAL		RLD, RS	2016-01-27

Orange Book patents#

Current patent rows page 1 of 1 · 18 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N206099-001	11571531	2026-02-23	U-1809		2023-05-19
N206099-001	10124132	2027-03-06	U-1719	Drug product	2018-12-10
N206099-001	10124132	2027-03-06	U-2010	Drug product	2018-12-10
N206099-001	10124132	2027-03-06	U-2011	Drug product	2018-12-10
N206099-001	10398859	2027-12-19		Drug product	2019-09-30
N206099-001	8875704	2028-04-07	U-1809	Drug product	2016-02-23
N206099-001	10722667	2028-12-30		Drug product	2020-08-25
N206099-001	10076615	2029-07-30	U-2010		2018-10-12
N206099-001	10076615	2029-07-30	U-2011		2018-10-12
N206099-001	10076615	2029-07-30	U-2404		2018-10-12
N206099-001	8550073	2029-10-22		Drug product	2016-02-23
N206099-001	8899229	2030-08-18		Drug product	2016-02-23
N206099-001	9649456	2030-10-21	U-1719	Drug product	2017-05-26
N206099-001	9649456	2030-10-21	U-2010	Drug product	2017-05-26
N206099-001	9649456	2030-10-21	U-2011	Drug product	2017-05-26
N206099-001	8978647	2030-12-06		Drug product	2016-02-23
N206099-001	10478574	2033-11-04	U-2404		2019-12-09
N206099-001	10076614	2034-10-20		Drug product	2018-10-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / INHALATION	RLD, RS	2016-01-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / INHALATION	RLD, RS	2016-01-27	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N206099-001	ONZETRA XSAIL	EQ 11MG BASE	POWDER / NASAL	RLD, RS	2016-01-27	`f41ea6bd6efb…`

Observed Orange Book patent history#

Patent history page 1 of 24 · 958 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N206099-001	11571531	2026-02-23	U-1809		2023-05-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10124132	2027-03-06	U-2010	Drug product	2018-12-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10124132	2027-03-06	U-1719	Drug product	2018-12-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10124132	2027-03-06	U-2011	Drug product	2018-12-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10398859	2027-12-19		Drug product	2019-09-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	8875704	2028-04-07	U-1809	Drug product	2016-02-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10722667	2028-12-30		Drug product	2020-08-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10076615	2029-07-30	U-2011		2018-10-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10076615	2029-07-30	U-2010		2018-10-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10076615	2029-07-30	U-2404		2018-10-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	8550073	2029-10-22		Drug product	2016-02-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	8899229	2030-08-18		Drug product	2016-02-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	9649456	2030-10-21	U-1719	Drug product	2017-05-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	9649456	2030-10-21	U-2011	Drug product	2017-05-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	9649456	2030-10-21	U-2010	Drug product	2017-05-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	8978647	2030-12-06		Drug product	2016-02-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10478574	2033-11-04	U-2404		2019-12-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N206099-001	10076614	2034-10-20		Drug product	2018-10-12	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N206099-001	11571531	2026-02-23	U-1809		2023-05-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10124132	2027-03-06	U-2010	Drug product	2018-12-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10124132	2027-03-06	U-1719	Drug product	2018-12-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10124132	2027-03-06	U-2011	Drug product	2018-12-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10398859	2027-12-19		Drug product	2019-09-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	8875704	2028-04-07	U-1809	Drug product	2016-02-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10722667	2028-12-30		Drug product	2020-08-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10076615	2029-07-30	U-2011		2018-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10076615	2029-07-30	U-2010		2018-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10076615	2029-07-30	U-2404		2018-10-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	8550073	2029-10-22		Drug product	2016-02-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	8899229	2030-08-18		Drug product	2016-02-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	9649456	2030-10-21	U-1719	Drug product	2017-05-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	9649456	2030-10-21	U-2011	Drug product	2017-05-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	9649456	2030-10-21	U-2010	Drug product	2017-05-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	8978647	2030-12-06		Drug product	2016-02-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10478574	2033-11-04	U-2404		2019-12-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206099-001	10076614	2034-10-20		Drug product	2018-10-12	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N206099-001	11571531	2026-02-23	U-1809		2023-05-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206099-001	10124132	2027-03-06	U-2010	Drug product	2018-12-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206099-001	10124132	2027-03-06	U-1719	Drug product	2018-12-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206099-001	10124132	2027-03-06	U-2011	Drug product	2018-12-10	`011fe1cb6892…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 3 · 46 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sumatriptan Succinate	SUMATRIPTAN SUCCINATE	Direct_Rx	f6c907a3-9624-f893-e053-6294a90a31af	2025-01-22	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan Succinate	SUMATRIPTAN SUCCINATE	NuCare Pharmaceuticals,Inc.	7628caf4-5272-4e42-e053-2a91aa0a2f24	2025-01-08	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	NuCare Pharmaceuticals, Inc.	2a96f37d-03f6-678c-e063-6394a90ae0c6	2024-12-31	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	Quality Care Products, LLC	5d1f3de0-684a-4092-be30-aa325ff20d04	2024-12-18	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	Quality Care Products, LLC	da77dfc4-551c-4e0e-a65e-cb478f193cd9	2024-12-18	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan Succinate	SUMATRIPTAN SUCCINATE	Direct_Rx	284ee7ac-759e-b592-e063-6394a90a78ba	2024-12-02	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan Succinate	SUMATRIPTAN SUCCINATE	NuCare Pharmaceuticals,Inc.	b297a466-7d24-9ebd-e053-2a95a90af4d1	2024-07-17	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	NuCare Pharmaceuticals,Inc.	54c6f8f4-5466-3988-e054-00144ff8d46c	2024-07-10	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	NuCare Pharmaceuticals,Inc.	933f6575-a4c4-0f65-e053-2a95a90ab967	2024-06-19		Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	NuCare Pharmaceuticals,Inc.	85295be9-852d-4e21-e053-2991aa0a8a78	2024-06-14	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan Succinate	SUMATRIPTAN SUCCINATE	Fresenius Kabi USA, LLC	b183c7ba-2cc6-4854-a9a6-71ccd3592586	2024-04-12	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
sumatriptan succinate	SUMATRIPTAN SUCCINATE	A-S Medication Solutions	97016a59-3b49-4134-85aa-8c866f285601	2023-11-22	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan Succinate	SUMATRIPTAN SUCCINATE	NorthStar Rx LLC	38fd19bf-b7aa-812c-8a74-2414dfec45f4	2023-03-01	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	Proficient Rx LP	fe09fab6-b9e3-469c-9a38-bcc343dcc899	2023-01-01	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	Asclemed USA, Inc.	77f9f135-e840-48f0-81e8-73e08433e768	2022-10-11	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	Proficient Rx LP	abbd2168-1523-4eb6-a75c-dc4d7d1b1c9b	2022-06-01	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	Proficient Rx LP	1042b91c-715c-4e90-b9cc-d91a17f9f7cb	2022-04-01	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
sumatriptan succinate	SUMATRIPTAN SUCCINATE	Proficient Rx LP	9f4d487a-c5f7-4707-976b-64e738c98d45	2022-04-01	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan Succinate	SUMATRIPTAN SUCCINATE	Dr. Reddy's Laboratories Limited	4e26764d-ce26-e5ac-e6db-0f1f7a1d5c2b	2021-12-21	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE
Sumatriptan	SUMATRIPTAN SUCCINATE	Xellia Pharmaceuticals USA LLC	f42c6e00-e693-48f3-8e84-c3f139e1adf5	2021-11-18	Warnings, Adverse reactions	Name fallback generic name: SUMATRIPTAN SUCCINATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
42847-311	Onzetra Xsail	sumatriptan succinate	Currax Pharmaceuticals LLC	NDA	Current
42847-311	Onzetra Xsail	sumatriptan succinate	Currax Pharmaceuticals LLC	NDA	Current
42847-311	Onzetra Xsail	sumatriptan succinate	Currax Pharmaceuticals LLC	NDA	Current
64597-311	ONZETRA	sumatriptan succinate	Avanir Pharmaceuticals, Inc.	NDA	Current
64597-311	ONZETRA	sumatriptan succinate	Avanir Pharmaceuticals, Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
61445	SUPPL	2019-12-26
61394	SUPPL	2019-12-23
59132	SUPPL	2019-06-20
59121	SUPPL	2019-06-19
23012	ORIG	2016-07-19
19705	ORIG	2016-02-18
10545	ORIG	2016-01-29